Atomization inhalation on the NO content in the airway of patients with bronchial asthma

Objective: clinical use atomization inhalation as adjuvant therapy, monitoring of exhaled NO content in patients with bronchial asthma airway, study of atomization inhalation effect about the existence of the NO content in the airway. Methods: select a 3 armour hospital respiratory asthma history for more than five years, no smoking, no patients with other diseases, 100 randomly selected as the research object. Experimental group in addition to the given routine therapy, randomly selected from 50 people, given budesonide suspension 2 mg and 0.48 mg salbutamol sulfate aerosol inhalation,; Physiological saline control group given conventional treatment, the use of placebo atomization inhalation, atomization inhalation once every seven hours, 2 times a day, at 0, 4, 8, respectively the NO concentration monitoring in the airway. Results: the experimental group was NO content in the airway in patients with bronchial asthma fall faster. Conclusion: use of budesonide suspension and salbutamol sulfate atomization can decrease the NO content in patients with bronchial asthma airway faster, make earlier control of the inflammation, which can be taken as reference to clinical treatment.